Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study
Year: 2001
Type: article
Study design: Clinical Trial
Source: Blood
Institution: University Hospital Ulm
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Universität Ulm
OpenAlex ID: W2120818780
